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Abstract 
The  gastrointestinal  manifestations  of
Henoch-Schönlein purpura include abdominal
pain,  gastrointestinal  bleeding,  intussuscep-
tion, and perforation. Protein-losing enteropa-
thy is rarely associated with Henoch-Schönlein
purpura. Two pediatric patients with Henoch-
Schönlein purpura who developed protein-los-
ing enteropathy are reported. Tc-99m human
serum albumin scintigraphy is useful in the
detection of protein-losing enteropathy.
Introduction
Henoch-Schönlein  purpura  (HSP),  an
immune-mediated  disorder,  preferentially
affecting  children.  It  is  characterized  by
petechiae,  arthralgia,  and  gastrointestinal
manifestations,  including  abdominal  pain,
gastrointestinal  bleeding,  intussusception,
and  perforation.
1 Histological  examination
reveals systemic necrotizing vasculitis of small
vessels. Protein-losing enteropathy (PLE) is a
rare complication of HSP, with only six previ-
ous pediatric reports.
2-7
Here, two pediatric HSP patients who devel-
oped PLE are reported, along with a literature
review.
Case Report
Case #1
A 4-year-old boy was hospitalized with col-
icky abdominal pain. There was no recent drug
exposure or immunization, and his family his-
tory was unremarkable.
Four  days  before  admission,  he  had  low
grade fever and vomiting, and was treated by a
family  physician.  Because  of  continuing
abdominal pain, he was admitted to our hospi-
tal  with  suspected  acute  gastroenteritis.  On
admission,  he  had  vomiting  and  abdominal
pain.  He  was  113  cm  tall  (±1.63  SD)  and
weighed 18.4 kg (±0.3 SD). His temperature
was 37.4°C, his pulse was 98/min, and his gen-
eral condition was poor, with abdominal ten-
derness but no guarding, and no purpura.
Admission laboratory tests showed leukocy-
tosis (19ﾥ10
9/L, 76.6% neutrophils), decreased
serum total protein (3.0 g/dL), albumin (1.8
g/dL,)  and  plasma  factor  XIII  activity  (17%),
and increased fibrinogen (204 mg/dL), throm-
bin-antithrombin  III  complex  (TAT)  (10.1
ng/mL), fibrin/fibrinogen degradation products
(FDP)  (22.4  ng/mL),  and  D-dimer  (24.1
mg/mL). The immunologic profile was normal
except for low IgG (386 mg/dL). The Guaiac
test for fecal occult blood was positive.
On the day after admission, he developed
bloody stool and purpura on the lower extrem-
ities  and  scrotum.  With  a  diagnosis  of  HSP
with  gastrointestinal  involvement,  pred-
nisolone  (1.5  mg/kg/day),  dalteparin  (75
U/kg/day), and urinastatin (2,500 U/kg/dose)
were started. There was marked edema of eye-
lids  and  upper  and  lower  extremities.  The
patient’s serum albumin decreased to 1.8 g/dL,
necessitating  albumin  infusion.  His  plasma
factor  XIII  activity  also  decreased  to  17%,
necessitating  human  antihemophilic  factor
XIII  fraction.  Plasma  factor  XIII  and  serum
albumin levels normalized by the 10th day. He
was discharged on the 35th day.
On plain abdominal CT (Figure 1), diffuse
wall thickening in the small bowel and colon
and a small amount of ascites were noted.
Tc  99m-human  serum  albumin  (HSA)
scintigraphy  showed  activity  in  the  stomach
and duodenum 60 min after injection, suggest-
ing PLE. During the course, no urine abnor-
malities were detected. His transient hypopro-
teinemia was likely due to PLE, because it nor-
malized as his abdominal symptoms improved.
Case #2
A 5-year-old boy was admitted with abdomi-
nal pain, vomiting, bloody stool, and a rash on
his legs. He had no recent drug exposure or
immunization, and his family history was unre-
markable. Seven days before admission, purpu-
ra developed on his nose and around his mouth,
followed by abdominal pain and purpura on the
upper and lower extremities, involving his but-
tocks one day later. HSP was diagnosed.
Because of continuing abdominal pain, he
was admitted to our hospital. On admission, he
had  vomiting,  abdominal  pain,  and  bloody
stool.  He  was  121.8  cm  tall  (±1.9  SD)  and
weighed 22.8 kg (±0.8 SD). His temperature
was 36.9°C, pulse was 90/min, and blood pres-
sure was 90/58 mmHg. His general condition
was poor, with abdominal tenderness but no
guarding, and purpura on the earlobes, lower
extremities, and scrotum.
Admission laboratory tests showed leukocy-
tosis (19.3ﾥ10
9/L, 88.0% neutrophils), elevated
C-reactive  protein  (7.06  mg/dL),  decreased
serum total protein (6.1 g/dL), albumin (3.1
g/dL),  and  plasma  factor  XIII  activity  (46%),
and  increased  TAT  (20.8  ng/mL),  FDP  (18.2
ng/mL),  and  D-dimer  (18.4  mg/mL).  The
Guaiac test for fecal occult blood was positive.
The  anti-streptolysin-O  (ASO)  titer  was  900
IU/mL, and the anti-streptokinase (ASK) titer
was 1,280 dil. A throat culture was positive for
a-hemolytic  Streptococcus.  Streptococcal
infection  was  diagnosed,  and  ABPC  (100
mg/kg/day) was given. With a diagnosis of HSP
with  gastrointestinal  involvement,  pred-
nisolone  (1.5  mg/kg/day),  dalteparin  (75
U/kg/day),  and  urinastatin  (2500  U/kg/dose)
were  started.  Plasma  factor  XIII  and  serum
albumin levels normalized by the 10
th day as
his abdominal symptoms improved.
On  abdominal  CT,  diffuse  wall  thickening
was  noted  in  the  stomach.  Tc-99m-HSA
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Figure  1.  On  abdominal  computerized
tomography,  diffuse  wall  thickening  is
noted  in  the  small  bowel  and  colon.  A
small amount of ascites is seen. [page 68] [Pediatric Reports 2010; 2:e20]
scintigraphy showed activity in the stomach 60
min  after  injection,  suggesting  PLE.  During
the  course,  no  urine  abnormalities  were
detected. 
Discussion
Gastrointestinal  manifestations  of  PLE
rarely occur with HSP. PLE is a rare condition
characterized by gastrointestinal loss of serum
protein  resulting  in  hypoproteinemia,  which
can cause edema, ascites, pleural and pericar-
dial  effusions,  and  malnutrition.  Increased
capillary  permeability  or  submucosal  hemor-
rhage and ulceration by vasculitis might cause
the protein loss.
2 PLE is rare in HSP, with only
eight reported pediatric cases, including our
two cases
2-7 (Table 1). These patients (7 boys, 1
girl; age range, 4 to 14 years) all had abdomi-
nal pain; four had several unusual complica-
tions (case ## 2, 3, 4, 6). Case #4
5 had abdom-
inal pain, but the stool was Guaiac-negative.
Moderate  hypoproteinemia  (4.9  g/dL)  and
hypoalbuminemia (2.5 g/dL) without protein-
uria were detected during the acute phase; the
serum  protein  levels  increased  gradually  on
steroid  therapy,  but  severe  neurological
involvement resulted from cerebral vasculitis.
Case  #6,
7 a  4-year-old  boy,  had  severe
esophagitis  and  multiple  ulcers  in  the
descending  duodenum  presenting  as  PLE.
However,  our  cases  had  PLE  without  other
complications.
Previously, the detection and quantification
of  gastrointestinal  protein  loss  primarily
involved  measurement  of  fecal  excretion  of
albumin labeled with I-125 or Cr-51 after intra-
venous tracer injection. However, stool collec-
tion is difficult, with false-positive results if
the stool specimen is contaminated with urine.
Subsequently, measurement of fecal excretion
of a1-antitrypsin was used to detect PLE.
8 This
serum  enzyme,  with  the  same  molecular
weight as albumin, resists proteolysis and is
not degraded when it leaks into the intestinal
lumen. However, this is difficult because stool
must  be  collected.  Recently,  Tc-99m  HAS
scintigraphy has been used to diagnose PLE by
documenting protein loss in the gut, which is
also useful for monitoring response to treat-
ment.
9-10 Our two patients were diagnosed as
having PLE because of hypoalbuminemia with-
out nephrosis or liver dysfunction, as well as
abnormal leakage of the radiotracer into the
gut on Tc-99m HSA scintigraphy. Tc-99m HAS
scintigraphy offers a rapid, safe, and conven-
ient way to screen and localize PLE. In HSP
patients, Tc-99m HSA scintigraphy is useful for
detecting PLE. 
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Case Report
Table 1. Pediatric Henoch-Schönlein purpura patients with protein-losing enteropathy.
Case Age (years)/sex Intestinal bleeding Treatment Other symptoms References
1 14/M (+) PSL Abdominal pain joint pain, peripheral pitting edema Reif et al., 1991
2
2 6/M (+) PSL Abdominal pain, urolithiasis, hydrops of the gallbladder, Bosioet al., 1993
3
pancreatic involvement, scrotal hemorrhage,
testicular swelling, pyeloureteritis
3 10/M (+) PSL, Abdominal pain, hydronephrosis, Kano et al., 1998
4
mPSL pulse gallbladder abnormalities, purpura nephritis
4 12/M (-) PSL abdominal pain, cerebral vasculitis, testicular swelling Bakkalo￿lu et al., 2000
5
5 8/F (?) PSL, F XIII Abdominal pain Kaneko et al., 20046
6 4/M (+) PSL Abdominal pain Dalgiç et al., 2005
7
7 4/M (+) PSL, F XIII, dalteparin, urinastatin Abdominal pain Present report
8 5/M (+) PSL, dalteparin, urinastatin Abdominal pain Present report
PSL, prednisolone; mPSL pulse, pulse of methylprednisolone; F XIII, human antihemophilic factor XIII fraction.